New ECommerce Platform to Benefit Both Medical
and Adult-Consumer Use Customers
TSX: ACB
EDMONTON, July 16, 2018 /CNW/ - Aurora Cannabis Inc.
("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today
that it has reached an agreement with Shopify Inc. ("Shopify"), one
of the world's leading multi-channel, online commerce companies, to
leverage the Shopify platform as Aurora's ecommerce engine for
medical and recreational cannabis distribution globally.
Working closely with Aurora Cannabis' industry-leading software
engineering team, Shopify will assist in transitioning Aurora's
current ecommerce site to a new, Shopify-developed platform,
improving the customer experience for Aurora's current medical and
future adult consumer use customers. One of the key benefits of the
Shopify platform is its rapid and seamless scalability as Aurora
executes on its domestic and international expansion strategy.
"Selecting Shopify allows Aurora to bring a world-class
ecommerce solution to our patients and future adult consumer use
customers," said Darryl Vleeming,
CIO of Aurora Cannabis Inc. "Shopify's unique, industry leading
platform provides a safe, secure and flexible ecommerce site that
we can build on as we execute our global growth initiatives and
enter new markets."
Loren Padelford, VP at Shopify,
added: "While both companies originate in Canada, this is a true global success story,
combining our industry-leading technology, helping to power the
international expansion of one of the global leaders in the
exciting and rapidly growing cannabis industry. The Shopify
platform will allow Aurora to provide a tailored customer
experience that embraces and adapts to the unique demands of both
consumers and regulators, adapted to the specific needs of the
various jurisdictions in which Aurora operates."
About Aurora
Headquartered in Edmonton,
Alberta, with funded capacity in excess of 430,000 kg per
year and sales and operations in 14 countries across five
continents, Aurora is one of the world's largest and leading
cannabis companies. Aurora is vertically integrated and
horizontally diversified across every key segment of the value
chain, from facility engineering and design to cannabis breeding
and genetics research, cannabis and hemp production, derivatives,
high value-add product development, home cultivation, wholesale and
retail distribution. Aurora, from day one of its existence, has
been steadfast in its respect for the cannabis community, the
culture and its pioneers, as well as has been a strong supporter of
and advocate for access to cannabis.
Highly differentiated from its peers, Aurora has established a
uniquely advanced, consistent and efficient production strategy,
based on purpose-built facilities that integrate leading-edge
technologies across all processes. Intended to be replicable and
scalable globally, these production facilities are designed to
produce cannabis of significant scale, with high quality,
industry-leading yields, and ultra-low per gram production costs.
Each of Aurora's facilities is built to meet European Union (EU)
GMP standards, and both its first production facility and its
wholly owned European medical cannabis distributor Pedanios have
achieved this level of certification.
In addition to the Company's rapid organic growth and strong
execution on strategic M&A, which to date includes nine
companies acquired - CanvasRX, Peloton Pharmaceutical, Pedanios, H2
Biopharma, Urban Cultivator, BC Northern Lights, Larssen, CanniMed
Therapeutics, and Anandia Labs - Aurora is distinguished by its
reputation as a partner of choice and employer of choice in the
global cannabis sector, having invested in and established
strategic partnerships with a range of leading innovators,
including: The Green Organic Dutchman Holdings Ltd. (TSX: TGOD),
Radient Technologies Inc. (TSXV: RTI), Hempco Food and Fiber Inc.
(TSXV: HEMP), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies
Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), Namaste
Technologies Inc. (TSXV: N), Evio Beauty Group (private), and
Alcanna Inc. (TSX: CLIQ).
Aurora's Common Shares trade on the TSX under the symbol "ACB",
and are a constituent of the S&P/TSX Composite Index.
For more information about Aurora, please visit our investor
website investor.auroramj.com.
Terry Booth, CEO
Aurora Cannabis Inc.
Forward Looking Statements
This news release includes statements containing certain
"forward-looking information" within the meaning of applicable
securities law ("forward-looking statements"). Forward-looking
statements are frequently characterized by words such as "plan",
"continue", "expect", "project", "intend", "believe", "anticipate",
"estimate", "may", "will", "potential", "proposed" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. These statements are only predictions.
Various assumptions were used in drawing the conclusions or making
the projections contained in the forward-looking statements
throughout this news release. Forward-looking statements are based
on the opinions and estimates of management at the date the
statements are made, and are subject to a variety of risks and
uncertainties and other factors that could cause actual events or
results to differ materially from those projected in the
forward-looking statements. The Company is under no obligation, and
expressly disclaims any intention or obligation, to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as expressly
required by applicable law.
Neither TSX nor its Regulation Services Provider (as that
term is defined in the policies of Toronto Stock Exchange) accepts
responsibility for the adequacy or accuracy of this
release.
SOURCE Aurora Cannabis Inc.